ArticleJTO clinical and research reports2023

A Phase 2 Single-Arm Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis NSCLC: Results for the First-Line Cohort of the OCEAN Study (LOGIK 1603/WJOG 9116L).

Kazushige Wakuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.